Get 20% Free Customization In This Report

Buy this report from - $3456

Vagus Nerve Stimulation Market by Product (Implantable VNS Devices and External VNS Devices), Application (Depression, Epilepsy, and Migraine), End User (Hospitals, Ambulatory Surgical Centers (ASCs), and Others), and Biomaterial (Ceramics, Metallic, and Polymeric) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Medical Devices & Supplies	LI_183968	Pages: NA	Jun 2018 \| 460 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Vagus nerve stimulation (VNS) therapy is designed to avoid seizures by sending consistent, mild pulses of electrical signals to the brain through the vagus nerve. These pulses are delivered by a device, which resembles a pacemaker. Vagus nerve is a part of the autonomic nervous system that controls involuntary functions of the body such as heart rate. It passes through the neck, which passes between the chest and abdomen to the lower part of the brain. VNS device is referred to as the "pacemaker of the brain," and is placed under the skin on the chest wall. A wire runs from it to the vagus nerve in the neck. Vagus nerve stimulators are used in treatment of intractable epilepsy and treatment-resistant depression.

The major factors that drive the growth of global vagus nerve stimulation market are increase in prevalence of neurological disorders as migraine and epilepsy among all age groups and positive clinical outcomes regarding the use of this technique. However, dearth of skilled professionals and high cost associated with neurostimulator devices restrict the market growth. Conversely, increase in R&D activities to expand the indications for the use of neurostimulators is expected to provide lucrative growth opportunities to the market. For instance, vagus nerve stimulation is being explored for managing diseases related to organs and muscle function connected to the vagus nerve.

The report global vagus nerve stimulation market is segmented based on product, application, end user, biomaterial, and geography. On the basis of product, the market is bifurcated as implantable VNS devices and external VNS devices. By application, it is categorized into depression, epilepsy, and migraine. In terms of biomaterial, it is divided into ceramics, metallic, and polymerics. In terms of end user, it is classified into hospitals, ambulatory surgical centers (ASCS), and others. Regionally, the market is analyzed in North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the market include Medtronic Plc., ElectroCore LLC, LivaNova Plc., Boston Scientific Corporation, Aleva Neurotherapeutics SA, BioControl Medical, Bioness Inc., EnteroMedics Inc., Nevro Corporation, and NeuroPace Inc.

Key Benefits

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global vagus nerve stimulation market.
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities across the geographies.
This report entails the detailed quantitative analysis of the current market and estimations from 2016 to 2023 to identify the prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
Region- and country-wise market conditions are comprehensively analyzed in the report.

Vagus Nerve Stimulation Market Key Segments:

By Product

Implantable VNS Devices
External VNS Devices

By Application

Depression
Epilepsy
Migraine

By Biomaterial

Ceramics
Metallic
Polymerics

By End User

Hospitals
Ambulatory Surgical Centers (ASCS)
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- South Korea
- India
- Rest of Asia-Pacific
LAMEA
- Brazil
- Venezuela
- Saudi Arabia
- South Africa
- Argentina
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 GLOBAL VAGUS NERVE STIMULATION (VNS) MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. IMPLANTABLE VNS DEVICES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. EXTERNAL VNS DEVICES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter: 5 GLOBAL VAGUS NERVE STIMULATION (VNS) MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. DEPRESSION

5.2.1. Market size and forecast

5.3. EPILEPSY

5.3.1. Market size and forecast

5.4. MIGRAINE

5.4.1. Market size and forecast

Chapter: 6 GLOBAL VAGUS NERVE STIMULATION (VNS) MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. AMBULATORY SURGICAL CENTERS (ASCS)

6.3.1. Market size and forecast

6.4. OTHERS

6.4.1. Market size and forecast

Chapter: 7 GLOBAL VAGUS NERVE STIMULATION (VNS) MARKET, BY BIOMATERIAL

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. CERAMICS

7.2.1. Market size and forecast

7.3. METALLIC

7.3.1. Market size and forecast

7.4. POLYMERIC

7.4.1. Market size and forecast

Chapter: 8 GLOBAL VAGUS NERVE STIMULATION (VNS) MARKET, BY REGION

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast

8.2.3.1. U.S. market size and forecast
8.2.3.2. Canada market size and forecast
8.2.3.3. Mexico market size and forecast

8.2.4. North America Vagus Nerve Stimulation Market by Product
8.2.5. North America Vagus Nerve Stimulation Market by Application
8.2.6. North America Vagus Nerve Stimulation Market by End User
8.2.7. North America Vagus Nerve Stimulation Market by Biomaterials

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast

8.3.3.1. Germany market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. UK market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast

8.3.4. Europe Vagus Nerve Stimulation Market by Product
8.3.5. Europe Vagus Nerve Stimulation Market by Application
8.3.6. Europe Vagus Nerve Stimulation Market by End User
8.3.7. Europe Vagus Nerve Stimulation Market by Biomaterials

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast

8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. Australia market size and forecast
8.4.3.4. India market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Rest of Asia-Pacific market size and forecast

8.4.4. Asia-Pacific Vagus Nerve Stimulation Market by Product
8.4.5. Asia-Pacific Vagus Nerve Stimulation Market by Application
8.4.5. Asia-Pacific Vagus Nerve Stimulation Market by End User
8.4.5. Asia-Pacific Vagus Nerve Stimulation Market by Biomaterials

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast

8.5.3.1. Brazil market size and forecast
8.5.3.2. Argentina market size and forecast
8.5.3.3. Venezuela market size and forecast
8.5.3.4. Saudi Arabia market size and forecast
8.5.3.5. South Africa market size and forecast
8.5.3.6. Rest of LAMEA market size and forecast

8.5.4. LAMEA Vagus Nerve Stimulation Market by Product
8.5.5. LAMEA Vagus Nerve Stimulation Market by Application
8.5.6. LAMEA Vagus Nerve Stimulation Market by end User
8.5.7. LAMEA Vagus Nerve Stimulation Market by Biomaterials

Chapter: 9 COMPANY PROFILES

9.1. MEDTRONIC PLC

9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments

9.2. ELECTROCORE LLC

9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments

9.3. LIVANOVA PLC

9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments

9.4. BOSTON SCIENTIFIC CORPORATION

9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments

9.5. ALEVA NEUROTHERAPEUTICS SA

9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments

9.6. BIOCONTROL MEDICAL

9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments

9.7. BIONESS INC.

9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments

9.8. ENTEROMEDICS INC.

9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments

9.9. NEVRO CORPORATION

9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments

9.10. NEUROPACE INC.

9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Shopping Cart is Empty..

Your Shopping Cart Is Empty